PREDNISOLONE SODIUM PHOSPHATE
PREDNISOLONE SODIUM PHOSPHATE
Approval overview PREDNISOLONE SODIUM PHOSPHATE is listed in Drugs@FDA under application 203559 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient PREDNISOLONE SODIUM PHOSPHATE Form and strength SOLUTION;ORAL - EQ 20MG BASE/5ML Sponsor EDENBRIDGE PHARMS Submission history Latest submission status date: 2024-06-05 00:00:00.
Structured Monograph
Clinical summary
Approval overview PREDNISOLONE SODIUM PHOSPHATE is listed in Drugs@FDA under application 203559 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient PREDNISOLONE SODIUM PHOSPHATE Form and strength SOLUTION;ORAL - EQ 20MG BASE/5ML Sponsor EDENBRIDGE PHARMS Submission history Latest submission status date: 2024-06-05 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.